Your session is about to expire
← Back to Search
Visual Feedback Gait Training for Stroke
N/A
Recruiting
Led By Amy J Bastian, PhD, PT
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults age 20-80
Patients able to walk for 5 minutes at their self-paced speed
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm.
Awards & highlights
Study Summary
This trial will test whether different forms of visual feedback can help people with stroke modify their gait pattern.
Who is the study for?
This trial is for adults aged 20-80 who have had a stroke or hemiparesis at least 6 months ago. Participants should be able to walk, even if they need a cane or walker, and must manage a 5-minute walk at their own pace. It's not suitable for those with certain neurological conditions other than stroke, severe communication difficulties due to aphasia, uncontrolled heart issues, diabetes, cognitive impairment (MoCA score <23), pregnancy, or walking limitations from orthopedic conditions.Check my eligibility
What is being tested?
The study tests how gait training with visual feedback on leg movements can help people who've had a stroke improve their walking patterns over time. The goal is to see if seeing one's own joint movements while walking helps retrain the brain and muscles to normalize the way participants walk.See study design
What are the potential side effects?
Since this intervention involves physical therapy techniques rather than medication, side effects may include muscle soreness or fatigue related to exercise. There might also be some frustration or psychological stress associated with learning new movement patterns.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 20 and 80 years old.
Select...
I can walk for 5 minutes at my own pace.
Select...
I had a stroke or weakness on one side of my body more than 6 months ago.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed before and after the gait training provided in each arm of the study to assess a change following each intervention. this measure will be collected during the first and last sessions of arms 1 and 2, occurring within two weeks for each arm.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
1. Change in hip and knee joint movements while walking
Secondary outcome measures
1. Change in walking speed
2. Change in subjective assessment of balance confidence
Trial Design
2Treatment groups
Experimental Treatment
Group I: Single Channel Visual FeedbackExperimental Treatment1 Intervention
Gait training with visual feedback of joint kinematics. The visual feedback will contain information about the lower limb joint angles. We will instruct subjects to use the feedback to reach a target walking pattern. In this arm, subjects will receive 1 channel of visual information that encompasses information from 4 lower limb joint angles (right and left hips, right and left knees).
Group II: Multichannel Visual FeedbackExperimental Treatment1 Intervention
Gait training with visual feedback of joint kinematics. The visual feedback will contain information about the lower limb joint angles. We will instruct subjects to use the feedback to reach a target walking pattern. In this arm, subjects will receive 4 channels of visual information, each of which represents a joint angle (right and left hips, right and left knees).
Find a Location
Who is running the clinical trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
88 Previous Clinical Trials
24,886 Total Patients Enrolled
2 Trials studying Stroke
126 Patients Enrolled for Stroke
National Institutes of Health (NIH)NIH
2,720 Previous Clinical Trials
7,494,234 Total Patients Enrolled
38 Trials studying Stroke
7,782 Patients Enrolled for Stroke
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,347 Previous Clinical Trials
650,714 Total Patients Enrolled
172 Trials studying Stroke
84,058 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have symptoms related to balance and coordination issues.I can walk but not perfectly, sometimes using a cane or walker.I have a neurological condition that is not a stroke.My diabetes is not under control.My blood pressure is not higher than 190/110 mmHg.I am between 20 and 80 years old.You have a severe language problem that makes it difficult to communicate.I have unstable chest pain.I have been diagnosed with congestive heart failure.I can walk for 5 minutes at my own pace.I have leg pain from walking due to poor blood flow.I do not have lung or kidney failure.I have a condition that makes it hard for me to walk.I had a stroke or weakness on one side of my body more than 6 months ago.Your test score for thinking and memory is less than 23.
Research Study Groups:
This trial has the following groups:- Group 1: Multichannel Visual Feedback
- Group 2: Single Channel Visual Feedback
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger